Morpholino Oligomer–Mediated Exon Skipping Averts the Onset of Dystrophic Pathology in the mdx Mouse

This publication has 41 references indexed in Scilit:

• RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
  Current Gene Therapy, 2005
• Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?
  Neuromuscular Disorders, 2005
• Gene Therapy: The ‘pro-sense’ approach to Duchenne muscular dystrophy
  European Journal of Human Genetics, 2005
• Dystrophin and mutations: one gene, several proteins, multiple phenotypes
  The Lancet Neurology, 2003
• Advances in Duchenne muscular dystrophy gene therapy
  Nature Reviews Genetics, 2003
• Muscular dystrophy into the new millennium
  Neuromuscular Disorders, 2002
• Novel dystrophin mutations revealed by analysis of dystrophin mRNA: alternative splicing suppresses the phenotypic effect of a nonsense mutation
  Neuromuscular Disorders, 2001
• Clinical variability in Becker muscular dystrophy Genetic, biochemical and immunohistochemical correlates
  Brain, 1994
• Searching for the 1 in 2,400,000: A review of dystrophin gene point mutations
  Human Mutation, 1994
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
  Genomics, 1988